Reading Time: 7 minutesNina Rzechorzek is based at the University of Edinburgh. In 2012 Nina’s article on Prof Siddharthan Chandran’s research was shortlisted for the Access to Understanding
Search Results for: clinical trial
Reading Time: 4 minutesDr Ruth Standring-Cox BSc DPhil explains about her link with MND and her research experience, including how research has moved on in the past 40
Reading Time: 2 minutesA lot has been happening in terms of research policy at the moment, from the announcement of the European adaptive licensing pilot to the Government’s Early Access to
Reading Time: 4 minutesLast month the UK Government’s Department of Health announced an Early Access to Medicines Scheme. But, what is this new scheme? and what does it
Reading Time: 5 minutesThe 24th International Symposium on ALS/MND was the most successful to date with over 950 clinicians, healthcare professionals and scientists attending the meeting in Milan.
Reading Time: 5 minutesThe International Symposium on ALS/MND is the largest MND-specific conference in the world, which is expected to attract over 900 delegates this year. The planning of
Reading Time: 3 minutesAfter we posted yesterday’s blog (Thursday 10 October) about Giovanna Mallucci’s research in Leicester, we received a report on the story from the President of the
Reading Time: 4 minutesThe only ‘proven’ treatment to slow the progression of MND is Riluzole. There are, however, many organisations offering expensive ‘unproven’ and ‘alternative’ treatments for MND.
Reading Time: 3 minutesEvery year in December the MND Association organizes the largest medical and scientific conference specific to MND in the world. The International Symposium on ALS/MND attracts over